Journals / Haydarpaşa Numune Medical Journal / 2021 / Cilt: 61 - Sayı: 2

The Effect of Fibromyalgia on Bone Mineral Density in Patients with Hypothyroidism

Pages
172–176
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, there was no difference in BMD between patients with both fibromyalgia and hypothyroidism and only with hypothyroidism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study was to investigate whether the presence of fibromyalgia affects the bone mineral density (BMD) in hypothyroid patients.
📊
Key Findings & Data:Methods: Our study consisted of three groups, including 30 patients with hypothyroidism and FMS, 30 patients with hy- pothyroidism, and 27 healthy volunteers.
💡
Conclusion & Impact:However, there was no difference in BMD between patients with both fibromyalgia and hypothyroidism and only with hypothyroidism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of this study was to investigate whether the presence of fibromyalgia affects the bone mineral density (BMD) in hypothyroid patients. Methods: Our study consisted of three groups, including 30 patients with hypothyroidism and FMS, 30 patients with hy- pothyroidism, and 27 healthy volunteers. Lumbar vertebrae and left proximal femur BMD measurements of groups were performed by dual-energy X-ray absorptiometry. Groups were compared in terms of BMD. Results: Lumbar spinal total T score and lumbar spinal total BMD were significantly different between healthy volunteers and the other two groups. However, no significant difference was found between the groups in terms of age, gender, body mass index, smoking and alcohol use habits, erythrocyte sedimentation rate, C-reactive protein, thyroid-stimulating hormone, fT3, fT4, and 25-OH Vitamin D. Discussion and Conclusion: BMD was lower in patients with hypothyroidism and in patients with both fibromyalgia and hypothyroidism compared with healthy individuals. However, there was no difference in BMD between patients with both fibromyalgia and hypothyroidism and only with hypothyroidism.

🔖

Cite This Article

KESKİN, Y., TAŞPINAR, Ö., KIZILTAN, H. Ş., AYDIN, T., ÜRKMEZ, B., ERİŞ, A. H., MUTLUER, A. S., ÇAMLI, A. A. (2022). The Effect of Fibromyalgia on Bone Mineral Density in Patients with Hypothyroidism. Haydarpaşa Numune Medical Journal, Cilt: 61 - Sayı: 2, 172–176. https://ajindex.com/articles/651402

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. McBeth J, MacFarlane GJ, Hunt I, Silman AJ. Risk factors for persistent chronic widespread pain: A community‐based study. Rheumatology 2001;40:95–101
  2. Branco JC, Bannwarth B, Failde I, Carbonell JA, Blotman J, Spa- eth M, et al. Prevalence of fibromyalgia: A survey in five Euro- pean countries. Semin Arthritis Rheum 2010;39:448–53
  3. Dessein P, Stanwix A. Why would fibromyalgia patients have osteoporosis? J Rheumatol 2000;27:1816–7
  4. Holick MF. Too little Vitamin D in premenopausal women: Why should we care? Am Soc Nutr 2002;76:3–4
  5. Reginato AJ, Falasca GF, Pappu R, McKnight B, Agha A. Muscu- loskeletal manifestations of osteomalacia: Report of 26 cases and literature review. Semin Arthritis Rheum 1999;28:287–304
  6. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thom- sen J, et al. Commonly recommended daily intake of Vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000;247:260–8
  7. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American college of rheumatology prelim- inary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600–10
  8. Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: Validation of the modified 2010 preliminary American college of rheu- matology criteria and the development of alternative criteria. Arthritis Care Res 2014;66:1364–73
  9. Aydın T, Taspınar O, Akbal Y, Peru C, Guler M, Uysal O, et al. Se- rum bone markers levels and bone mineral density in familial mediterranean fever. J Phys Ther Sci 2014;26:1459–63
  10. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S, et al. Low bone mass in premenopausal women with depression. Arch Intern Med 2007;167:2329–36
  11. Wolfe F, Allen M, Bennett RM, Boonen A, Buskila D, Carville S, et al. The fibromyalgia syndrome: A consensus report on fibro- myalgia and disability. J Rheumatol 1996;23:534–39
  12. Faber J, Galløe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: A meta-analysis. Eur J Endocrinol 1994;130:350–6
  13. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thy- roid hormones: A meta-analysis. J Clin Endocrinol Metab 1996;81:4278–89
  14. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012;379:1142–54
  15. Vestergaard P, Mosekilde L. Fractures in patients